The Cooper Companies Inc (COO)
100.80
+0.89
(+0.89%)
USD |
NASDAQ |
Nov 22, 16:00
100.80
0.00 (0.00%)
After-Hours: 20:00
Cooper Cash from Financing (Quarterly): -87.60M for July 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | -87.60M |
April 30, 2024 | -57.10M |
January 31, 2024 | 212.30M |
October 31, 2023 | -6.50M |
July 31, 2023 | -43.00M |
April 30, 2023 | -46.80M |
January 31, 2023 | -77.60M |
October 31, 2022 | -134.10M |
July 31, 2022 | -368.70M |
April 30, 2022 | 2.90M |
January 31, 2022 | 1.694B |
October 31, 2021 | -123.80M |
July 31, 2021 | -108.60M |
April 30, 2021 | -65.40M |
January 31, 2021 | -13.60M |
October 31, 2020 | -85.30M |
July 31, 2020 | -18.60M |
April 30, 2020 | 71.60M |
January 31, 2020 | -63.20M |
October 31, 2019 | -139.10M |
July 31, 2019 | -103.60M |
April 30, 2019 | -201.90M |
January 31, 2019 | 93.20M |
October 31, 2018 | -263.30M |
July 31, 2018 | -188.60M |
Date | Value |
---|---|
April 30, 2018 | 78.90M |
January 31, 2018 | 1.217B |
October 31, 2017 | -67.00M |
July 31, 2017 | -170.90M |
April 30, 2017 | -73.50M |
January 31, 2017 | 83.50M |
October 31, 2016 | -102.90M |
July 31, 2016 | 29.00M |
April 30, 2016 | 54.70M |
January 31, 2016 | 17.80M |
October 31, 2015 | -2.528M |
July 31, 2015 | -29.68M |
April 30, 2015 | -54.24M |
January 31, 2015 | -20.25M |
October 31, 2014 | 872.25M |
July 31, 2014 | 40.04M |
April 30, 2014 | -11.54M |
January 31, 2014 | -58.58M |
October 31, 2013 | -23.46M |
July 31, 2013 | -51.81M |
April 30, 2013 | -72.20M |
January 31, 2013 | -14.12M |
October 31, 2012 | -82.25M |
July 31, 2012 | 94.38M |
April 30, 2012 | -60.37M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-368.70M
Minimum
Jul 2022
1.694B
Maximum
Jan 2022
35.82M
Average
-57.10M
Median
Apr 2024
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 7.00M |
Staar Surgical Co | 1.615M |
OrthoPediatrics Corp | 58.52M |
NexGel Inc | 1.214M |
Innovative Eyewear Inc | 5.034M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 207.50M |
Cash from Investing (Quarterly) | -124.10M |
Free Cash Flow | 189.20M |
Free Cash Flow Per Share (Quarterly) | 0.5907 |
Free Cash Flow to Equity (Quarterly) | 198.90M |
Free Cash Flow to Firm (Quarterly) | 136.73M |
Free Cash Flow Yield | 0.94% |